Ankylosing spondylitis treatment market is witnessing steady growth, projected to expand from $6.5 billion in 2025 to $11.2 billion by 2035, registering a CAGR of 5.6% during the forecast period (2026–2035). The market is driven by the rising prevalence of chronic inflammatory diseases, increasing biologic drug adoption, and expanding access to advanced therapeutics across emerging economies. A key macro driver supporting this growth is the rising burden of musculoskeletal and autoimmune disorders globally. According to the World Health Organization (WHO), musculoskeletal conditions affect over 1.71 billion people worldwide, making them the leading contributor to disability. Ankylosing spondylitis (AS), a chronic inflammatory disease affecting the spine, is a significant subset of this burden. Furthermore, data from the U.S. Food and Drug Administration (FDA) indicate increasing approvals for biologic and targeted therapies in autoimmune diseases, accelerating treatment availability and innovation. This growing disease prevalence, combined with improved diagnostic rates, is directly translating into higher treatment demand, thereby strengthening the ankylosing spondylitis treatment market.

Amphibious excavator market was valued at $395.1 million in 2025 and is projected to reach $706.9 million by 2035, growing at a CAGR of 6.0% during the forecast period from 2026 to 2035. The market growth is being fueled by rising investments in coastal infrastructure development, wetland restoration projects, dredging operations, flood control systems, and marine construction activities worldwide. Amphibious excavators are increasingly being adopted for operations in swampy terrains, marshlands, rivers, canals, and shallow water environments where conventional excavation equipment faces operational limitations.

North America oncology information system market was valued at $1.5 billion in 2025 and is expected to reach $3.3 billion by 2035, registering a CAGR of 8.8% during the forecast period (2026–2035). This growth is driven by the rising prevalence of cancer and increasing demand for digital healthcare solutions across the region. Healthcare providers are adopting advanced oncology information systems to streamline clinical workflows and improve patient management. In 2026, Frontiers Media published a study highlighting the role of AI in enhancing diagnostic accuracy, clinical decision-making, and oncology training. These advancements are strengthening digital oncology ecosystems, enabling efficient treatment planning, accurate diagnosis, and integrated data management, thereby encouraging greater adoption across hospitals and cancer treatment centers.

Silent attack market is projected to grow from $$5.2 billion in 2025 and is projected to reach $10.5 billion by 2035, growing at a CAGR of 7.3% during the forecast period 2026-2035. The global silent heart attack market is being shaped by the increasing recognition of asymptomatic cardiac events, particularly among individuals with chronic conditions such as diabetes, kidney disorders, and advanced age. Clinical evidence indicates that these events often occur without typical symptoms due to neurological and metabolic factors, which has led to a stronger emphasis on proactive screening and risk stratification. Healthcare systems are gradually incorporating routine cardiac assessments into broader disease management programs to address this gap in detection. At the same time, the growing burden of cardiovascular risk factors linked to lifestyle changes is reinforcing the need for earlier identification approaches. Greater clinical awareness of undetected myocardial injury is also influencing diagnostic protocols in both primary and specialized care settings. These factors collectively support a shift toward more systematic and preventive cardiac evaluation practices.

Adalimumab market is projected to grow from $10.8 billion in 2025 to $21.5 billion by 2035, registering a CAGR of 7.1% during the forecast period from 2026 to 2035. Rising prevalence of autoimmune disorders, increasing biologic therapy adoption, and expanding biosimilar penetration are major growth drivers supporting global market expansion. According to the World Health Organization, approximately 18 million people worldwide were living with rheumatoid arthritis in 2019, with autoimmune disorders continuing to increase globally due to aging populations and chronic inflammatory disease burden. This growing patient population is significantly driving demand for TNF-alpha inhibitors such as adalimumab across hospitals, specialty clinics, and home care settings. Additionally, the U.S. FDA continues to accelerate biosimilar approvals to improve biologic affordability and treatment access.

Germany sleep-wake disorder market is projected to grow from $1.6 billion in 2025 and is projected to reach $3.0 billion by 2035, growing at a CAGR of 6.4% during the forecast period 2026-2035. The German sleep-wake disorder market is shaped by a growing clinical focus on sleep-related conditions such as insomnia, sleep apnea, and circadian rhythm disruptions. Increasing awareness among patients and healthcare providers is contributing to higher diagnosis rates, although a significant portion of sleep disorders remains under-recognized in routine clinical practice. The country’s well-developed healthcare system and strong neurological and respiratory care infrastructure support structured diagnosis and treatment pathways. At the same time, improved screening approaches and expanded use of sleep laboratories and home-based diagnostic tools are strengthening the identification and management of sleep-wake disorders across different patient groups.

Germany dredging hose market was valued at $7.6 million in 2025 and is projected to reach $10.8 million by 2035, registering a CAGR of 3.5% during the forecast period from 2026 to 2035. The market is witnessing steady growth due to increasing investments in port modernization, coastal protection projects, and the expansion of maritime logistics infrastructure across Germany and Europe. Growing demand for efficient dredging operations in ports, waterways, and offshore construction activities is driving the adoption of advanced dredging hose systems. In addition, the expansion of marine trade activities and rising focus on maintaining navigational channels are creating significant opportunities for hose manufacturers operating in the dredging industry.

Floating dredging hose market was valued at $125.3 million in 2025 and is projected to reach $177.4 million by 2035, registering a CAGR of 3.6% during the forecast period from 2026 to 2035. Market growth is driven by increasing investments in marine infrastructure, offshore construction, port expansion, and coastal protection projects worldwide. Floating dredging hoses are widely used for transporting slurry, sediments, and abrasive materials in dredging operations due to their flexibility, buoyancy, and high durability in harsh marine environments. Rising demand for efficient dredging systems in harbor maintenance and land reclamation activities is further contributing to market expansion.

European sleep-wake disorder market is projected to grow from $6.0 billion in 2025 and is projected to reach $10.7 billion by 2035, growing at a CAGR of 6.0% during the forecast period 2026-2035. The European sleep-wake disorder market is experiencing steady development due to increasing awareness regarding the long-term health effects associated with untreated sleep conditions. Healthcare providers across the region are placing greater emphasis on early diagnosis and integrated treatment approaches for disorders such as insomnia, sleep apnea, and circadian rhythm disturbances. The expansion of specialized sleep clinics and the growing availability of home-based diagnostic tools are supporting broader patient access to care. In addition, changing work patterns, rising stress levels, and lifestyle-related health concerns are contributing to higher demand for sleep management solutions. Public health initiatives promoting mental wellness and preventive healthcare are also influencing the adoption of sleep-related therapies and monitoring systems.

European dredging hose market was valued at $38.2 million in 2025 and is projected to reach $52.8 million by 2035, growing at a CAGR of 3.3% during the forecast period (2026–2035). Market expansion is primarily supported by increasing maritime trade activities and continuous investments in port infrastructure development across Europe. The growing need for efficient sediment management and maintenance of navigable waterways is further accelerating the demand for advanced dredging equipment. Additionally, large-scale coastal protection and land reclamation initiatives are contributing to sustained market growth. The rising focus on enhancing port capacity and operational efficiency is also encouraging the adoption of durable and high-performance dredging hoses. The continued movement of energy resources and expansion of maritime logistics networks are expected to support the use of dredging hoses in applications including port maintenance, oil & gas transfer, and land reclamation projects across Europe.